X-47200987-C-T
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4BP6BS2
The NM_003334.4(UBA1):c.574C>T(p.Arg192Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000317 in 1,197,425 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 16 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_003334.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UBA1 | NM_003334.4 | c.574C>T | p.Arg192Trp | missense_variant | 6/26 | ENST00000335972.11 | NP_003325.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
UBA1 | ENST00000335972.11 | c.574C>T | p.Arg192Trp | missense_variant | 6/26 | 1 | NM_003334.4 | ENSP00000338413.6 |
Frequencies
GnomAD3 genomes AF: 0.0000446 AC: 5AN: 112117Hom.: 0 Cov.: 23 AF XY: 0.0000583 AC XY: 2AN XY: 34289
GnomAD3 exomes AF: 0.0000697 AC: 11AN: 157811Hom.: 0 AF XY: 0.0000599 AC XY: 3AN XY: 50079
GnomAD4 exome AF: 0.0000304 AC: 33AN: 1085308Hom.: 0 Cov.: 31 AF XY: 0.0000396 AC XY: 14AN XY: 353460
GnomAD4 genome AF: 0.0000446 AC: 5AN: 112117Hom.: 0 Cov.: 23 AF XY: 0.0000583 AC XY: 2AN XY: 34289
ClinVar
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 13, 2021 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Infantile-onset X-linked spinal muscular atrophy Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at